Stay updated on CC-486 and MK-3475 in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.

Latest updates to the CC-486 and MK-3475 in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe site revision displayed in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study record content. This reflects an access-blocked state rather than the study information.SummaryDifference20%

- Check22 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 on the study details page.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision: v3.6.6 was added to the page, replacing the previous Revision: v3.6.5. This indicates a recent update to the page's documentation or backend versioning.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a software patch or maintenance update to the site. This change reflects behind-the-scenes updates rather than modifications to the study details displayed on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedTerminated status is now shown and Berlin, State of Berlin, Germany, 13125 is added as a trial location. Additionally, definitions for RECIST v1.1 and disease control rate are added/clarified, along with a PDF and protocol document linked on the page, detailing the study’s outcome measures and supporting materials.SummaryDifference1%

Stay in the know with updates to CC-486 and MK-3475 in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.